Literature DB >> 17698826

Drug interactions with warfarin: what clinicians need to know.

David N Juurlink1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17698826      PMCID： PMC1942100          DOI： 10.1503/cmaj.070946

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

Review 1.  Interaction of warfarin with drugs, natural substances, and foods.

Authors:  David J Greenblatt; Lisa L von Moltke
Journal:  J Clin Pharmacol       Date:  2005-02       Impact factor: 3.126

2.  Performance of community pharmacy drug interaction software.

Authors:  T K Hazlet; T A Lee; P D Hansten; J R Horn
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Mar-Apr

Review 3.  Nonsteroidal antiinflammatory drugs and the small intestine.

Authors:  Paul J Fortun; Christopher J Hawkey
Journal:  Curr Opin Gastroenterol       Date:  2007-03       Impact factor: 3.287

Review 4.  Systematic overview of warfarin and its drug and food interactions.

Authors:  Anne M Holbrook; Jennifer A Pereira; Renee Labiris; Heather McDonald; James D Douketis; Mark Crowther; Philip S Wells
Journal:  Arch Intern Med       Date:  2005-05-23

5.  The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K.

Authors:  J M Conly; K Stein; L Worobetz; S Rutledge-Harding
Journal:  Am J Gastroenterol       Date:  1994-06       Impact factor: 10.864

6.  Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.

Authors:  Daniel C Malone; Jacob Abarca; Philip D Hansten; Amy J Grizzle; Edward P Armstrong; Robin C Van Bergen; Babette S Duncan-Edgar; Steven L Solomon; Richard B Lipton
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Mar-Apr

7.  Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle.

Authors:  Henk H Thijssen; Berry A Soute; Lily M Vervoort; Jolanda G Claessens
Journal:  Thromb Haemost       Date:  2004-10       Impact factor: 5.249

8.  Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.

Authors:  Joseph A Delaney; Lucie Opatrny; James M Brophy; Samy Suissa
Journal:  CMAJ       Date:  2007-08-14       Impact factor: 8.262

9.  The influence of selective serotonin reuptake inhibitors on human platelet serotonin.

Authors:  Elisabeth Maurer-Spurej; Cheryl Pittendreigh; Kevin Solomons
Journal:  Thromb Haemost       Date:  2004-01       Impact factor: 5.249

Review 10.  Pharmacogenetics of warfarin elimination and its clinical implications.

Authors:  H Takahashi; H Echizen
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577
  10 in total
  20 in total

1.  Antiepileptic drugs and warfarin.

Authors:  S Nizam Ahmed
Journal:  CMAJ       Date:  2008-01-01       Impact factor: 8.262

Review 2.  Pharmacogenetics of warfarin: challenges and opportunities.

Authors:  Ming Ta Michael Lee; Teri E Klein
Journal:  J Hum Genet       Date:  2013-05-09       Impact factor: 3.172

3.  Multivariate analysis of the relation between diet and warfarin dose.

Authors:  Morten Arendt Rasmussen; Jane Skov; Else-Marie Bladbjerg; Johannes J Sidelmann; Marianne Vamosi; Jørgen Jespersen
Journal:  Eur J Clin Pharmacol       Date:  2011-09-21       Impact factor: 2.953

4.  Plenty of pills: polypharmacy prevails in patients of a Danish anticoagulant clinic.

Authors:  Jane Skov; Else-Marie Bladbjerg; Johannes Sidelmann; Marianne Vamosi; Jørgen Jespersen
Journal:  Eur J Clin Pharmacol       Date:  2011-05-12       Impact factor: 2.953

5.  A population-based assessment of the drug interaction between levothyroxine and warfarin.

Authors:  D Pincus; T Gomes; C Hellings; H Zheng; J M Paterson; M M Mamdani; D N Juurlink
Journal:  Clin Pharmacol Ther       Date:  2012-10-24       Impact factor: 6.875

6.  Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults.

Authors:  Jacques Baillargeon; Holly M Holmes; Yu-Li Lin; Mukaila A Raji; Gulshan Sharma; Yong-Fang Kuo
Journal:  Am J Med       Date:  2012-02       Impact factor: 4.965

7.  Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics.

Authors:  Charles E Leonard; Colleen M Brensinger; Warren B Bilker; Stephen E Kimmel; Xu Han; Young Hee Nam; Joshua J Gagne; Margaret J Mangaali; Sean Hennessy
Journal:  Int J Cardiol       Date:  2016-11-12       Impact factor: 4.164

8.  Novel anticoagulants in atrial fibrillation stroke prevention.

Authors:  Nicholas B Norgard; James J Dinicolantonio; Taylor J Topping; Benjamin Wee
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

9.  Development of a chiral micellar electrokinetic chromatography-tandem mass spectrometry assay for simultaneous analysis of warfarin and hydroxywarfarin metabolites: application to the analysis of patients serum samples.

Authors:  Xiaochun Wang; Jingguo Hou; Michael Jann; Yuen Yi Hon; Shahab A Shamsi
Journal:  J Chromatogr A       Date:  2012-11-26       Impact factor: 4.759

Review 10.  Warfarin Pharmacogenetics: New Life for an Old Drug.

Authors:  Ming-Shien Wen; Ming Ta Michael Lee
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.